CNS & Neurological Disorders - Drug Targets
Title:Commentary: Fatal French Clinical Trial: What Can We Learn from What Went Wrong?
Volume: 15 Issue: 7
Author(s): Stephen D. Skaper
Affiliation:
Export Options
About this article
Cite this article as:
Skaper D. Stephen, Commentary: Fatal French Clinical Trial: What Can We Learn from What Went Wrong?, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200336
DOI https://dx.doi.org/10.2174/187152731507160808200336 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
76
4
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Impact of Salt Concentration and pH on Surface Charged Residues: Controlling Protein Association Pathways in Carboxylesterase EstGtA2
Protein & Peptide Letters Chronopharmaceutics Based Modern Colon Specific Drug Delivery Systems
Current Drug Discovery Technologies The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Chitooligosaccharides as Antibacterial, Antibiofilm, Antihemolytic and Anti-Virulence Agent against Staphylococcus aureus
Current Pharmaceutical Biotechnology Clinical Applications of Pinhole Single Photon Emission Tomography
Current Medical Imaging Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Dietary Antioxidants: Immunity and Host Defense
Current Topics in Medicinal Chemistry AIDS-Defining Illnesses: A Comparison Between Before and After Commencement of Highly Active Antiretroviral Therapy (HAART)
Current HIV Research Applications of Chemical Shift Imaging for AD
Current Medical Imaging Influence of Transition Metal Ion Doping on the Crystallization and Photocatalytic Activity of TiO<sub>2</sub> Prepared Via Adsorption Phase Synthesis
Current Nanoscience Pharmacological Treatment of Obesity: Current Standards and Future Perspectives
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Does Ligand Symmetry Play a Role in the Stabilization of DNA G-Quadruplex Host-Guest Complexes?
Current Medicinal Chemistry Synergy of Deep Eutectics and Magnetite in NanoFe3O4@Choline Chloride: 2Urea as a New Reusable Catalyst for Synthesis of Pyrazoles
Current Catalysis Association Between 5HT1b Receptor Gene and Methamphetamine Dependence
Current Neuropharmacology The Metabolomic Strategy in Tuberculosis Therapy
Combinatorial Chemistry & High Throughput Screening The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia
Current Pharmaceutical Design Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and Dependence
Current Drug Research Reviews Inhibition of RAGE Axis Signaling: A Pharmacological Challenge
Current Drug Targets